TGFB1 and myalgic encephalomeyelitis/chronic fatigue syndrome: In conclusion, miR-7a/b has an anti-fibrotic role in ANG II-treated CFs that is mediated by Sp1 mechanism involving the TGF-β and MAPKs pathways.